Visual electrophysiology is a powerful, non-invasive tool in ophthalmology and neurology. It is of paramount importance in the diagnosis of diseases affecting the visual pathway because it objectively and specifically assesses function, localising dysfunction to the retinal pigment epithelium, retina, macula, optic nerve, chiasm or higher visual processing centres [1]. Crucially, it bridges objective structural information provided by imaging and examination, and psychophysical clinical observations such as acuity or visual fields. Clinical visual electrophysiology, therefore, is a necessary component of ophthalmic and neurological practice.
Outwith the clinic, visual electrophysiology delivers objective and quantifiable data and therefore is increasingly used in deep phenotyping and in clinical trials: at the time of writing, over 200 active clinical trials are using electrophysiological outcome measures. It is particularly helpful in animal models and hence has been instrumental in delivering some of the key therapies for sight-threatening disease [2].
By 1958, clinical electroretinography had reached the critical mass needed to form a society, the International Society for Clinical Electroretinography (ISCERG). At its first meeting in 1961, it was recognised that “the most urgent task of the Society is to establish certain standards” [3]. Ragnar Arthur Granit, a founding member of ISCERG, shared the 1967 Nobel Prize in Physiology or Medicine for using the electroretinogram (ERG) to discover “primary physiological and chemical visual processes in the eye”. In his Nobel Lecture, he praised Gösta Karpe, another ISERG founder, for making the ERG a “useful clinical method, nowadays considerably developed and employed all over the world” [4]. These early descriptions of clinical methods paved the way for an international standard [5,6,7]. The critical role of the ERG for understanding retinitis pigmentosa led to a collaboration between the Society, by then named the International Society for Clinical Electrophysiology of Vision (ISCEV), and the National Retinitis Pigmentosa Foundation of the USA. Led by Michael F. Marmor, the first international ERG Standard [8] was published in 1989.
The ERG Standard [9] is being revised for the seventh time, and four further Standards, for the visual evoked potential (VEP) [10], the pattern ERG [11], the multifocal ERG [12] and the electrooculogram [13], are updated periodically by ISCEV. Recognising that these Standards each describe a minimum test set, and in response to an international survey of actual practice, eight extended protocols have also been published. These extend standard testing to specific cortical or retinal functions; for example, the VEP can be used to estimate visual acuity [14]. On- and off-pathway testing aids in the diagnosis of congenital stationary night-blindness, melanoma-associated retinopathy, phosphomannomutase deficiency and autoimmune retinopathy [15]. S-cone ERGs can refine diagnosis in enhanced S-cone syndrome, distinguish rod monochromacy from S-cone monochromacy, and may help diagnose inherited tritanopia or elevated tritan thresholds [16]. Stimulus-response series of light- or dark-adapted ERGs add information about the aetiology or prognosis of diseases primarily affecting cone [17] or rod system function [18]. Dark-adapted red flash ERGs aid diagnosis of rod- and S-cone monochromacy, cone dystrophy, vitamin A deficiency, RDH5-retinopathy, SAG- or GRK1-retinopathy, some cases of rod-cone dystrophy, RGS9- and R9AP-retinopathy and colour vision deficiencies [19]. The photopic negative response reveals ganglion cell pathology in patients with glaucoma, optic atrophy, central retinal artery occlusion, ischaemic optic neuropathy, diabetic retinopathy, and idiopathic intracranial hypertension [20]. The strong flash rod-isolated ERG a-wave can aid understanding of diseases affecting the rod system: this extended protocol is ready to facilitate the move from research to clinic [21].
The primary aim of standards in clinical visual electrophysiology was to ensure that recordings between clinics or centres were comparable [3], and the evidence suggests this aim has been met: a multi-centre ERG study conducted in the UK demonstrated remarkably low variability, corresponding with acceptable variability of biochemical assays [22]. The Standards represent a cornerstone of clinical visual electrophysiology, embedding comparability and repeatability in the tests to an extent rarely achieved in clinical or laboratory measurement.
What lies ahead? Healthcare is changing, albeit differently in different parts of the world. What should clinical electrophysiology look like as we move away from episodic, illness-driven healthcare encounters, towards universal genotyping for susceptibility to ophthalmic disease? What should it look like in developing economies or in remote communities? What should it look like in a data-driven world, and an imaging-driven world? The service delivery model will need to diversify: retaining complex, detailed assessments at specialist centres, while developing alternative, accessible ways to deliver these essential tests to the huge numbers of people who cannot yet access their benefit. The tests need to be quicker and easier, diagnostically more robust, less onerous for patients and trial subjects, and more widely available. Change is already happening, as handheld and more compact systems arrive on the market, bringing clinical visual electrophysiology into theatres, wards, intensive care settings and even community settings. Innovations transforming other areas of clinical measurement—wireless electrodes [23], virtual reality, advanced signal processing [24], eye-tracking, machine learning, harmonised reference data [25]—have yet to impact clinical visual electrophysiology. The opportunity exists to leverage the diverse scientific, technical, clinical and commercial skills of the visual electrophysiology community and evolve these important tests for 21st century healthcare.
References
Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018;136:1–26.
Brigell M, Dong C-J, Rosolen S, Tzekov R. An overview of drug development with special emphasis on the role of visual electrophysiological testing. Doc Ophthalmol. 2005;110:3–13.
Karpe G. ISCERG: first symposium of electroretinography. Acta Ophthalmol Suppl. 1962;70:15–31.
Granit R. The development of retinal neurophysiology. Science. 1968;160:1192–6.
Karpe G. A routine method of clinical electroretinography. Acta Ophthalmol. 1962;40:15–31.
Van Der Tweel LH, Carr R, Hellner KA, Lawwill T, Van Lith GHM, Tazawa Y. Report of the committee on instrumentation and procedures in visual electrophysiology at the request of the concilium ophthalmologicum universale. Doc Ophthalmol. 1981;51:383–95.
Kooijman A, Vannorren D, Desera P, Thijssen J, Vanderheijde G, Reits D, et al. Minimum procedures for visual electrodiagnostic testing. Doc Ophthalmol. 1986;62:13–18.
Marmor MF. Standard for clinical electroretinography: International Standardization Committee. Arch Ophthalmol. 1989;107:816.
McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130:1–12.
Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133:1–9.
Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, et al. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;124:1–13.
Hoffmann MB, Bach M, Kondo M, Li S, Walker S, Holopigian K, et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update). Doc Ophthalmol. 2021;142:5–16.
Constable PA, Bach M, Frishman LJ, Jeffrey BG, Robson AG. International Society for Clinical Electrophysiology of Vision. ISCEV Standard for clinical electro-oculography (2017 update). Doc Ophthalmol. 2017;134:1–9.
Hamilton R, Bach M, Heinrich SP, Hoffmann MB, Odom JV, McCulloch DL, et al. ISCEV extended protocol for VEP methods of estimation of visual acuity. Doc Ophthalmol. 2021;142:17–24.
Sustar M, Holder GE, Kremers J, Barnes CS, Lei B, Khan NW, et al. ISCEV extended protocol for the photopic On–Off ERG. Doc Ophthalmol. 2018;136:199–206.
Perlman I, Kondo M, Chelva E, Robson AG, Holder GE. ISCEV extended protocol for the S-cone ERG. Doc Ophthalmol. 2020;140:95–101.
McCulloch DL, Kondo M, Hamilton R, Lachapelle P, Messias AMV, Robson AG, et al. ISCEV extended protocol for the stimulus-response series for light-adapted full-field ERG. Doc Ophthalmol. 2019;138:205–15.
Johnson MA, Jeffrey BG, Messias AMV, Robson AG. ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave. Doc Ophthalmol. 2019;138:217–27.
Thompson DA, Fujinami K, Perlman I, Hamilton R, Robson AG. ISCEV extended protocol for the dark-adapted red flash ERG. Doc Ophthalmol. 2018;136:191–7.
Frishman L, Sustar M, Kremers J, McAnany JJ, Sarossy M, Tzekov R, et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol. 2018;136:207–11.
Brigell M, Jeffrey BG, Mahroo OA, Tzekov R. ISCEV extended protocol for derivation and analysis of the strong flash rod-isolated ERG a-wave. Doc Ophthalmol. 2020;140:5–12.
Hamilton R, Al Abdlseaed A, Healey J, Neveu MM, Brown L, Keating D, et al. Multi-centre variability of ISCEV standard ERGs in two normal adults. Doc Ophthalmol. 2015;130:83–101.
Debener S, Emkes R, De Vos M, Bleichner M. Unobtrusive ambulatory EEG using a smartphone and flexible printed electrodes around the ear. Sci Rep. 2015;5:16743.
Zhang Y, Zhou G, Jin J, Wang X, Cichocki A. Frequency recognition in SSVEP-based BCI using multiset canonical correlation analysis. Int J Neural Syst. 2014;24:1450013.
Koerbin G, Sikaris KA, Jones GRD, Ryan J, Reed M, Tate J. Evidence-based approach to harmonised reference intervals. Clin Chim Acta. 2014;432:99–107.
Author information
Authors and Affiliations
Contributions
RH wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
RH is the current President of the International Society for Clinical Electrophysiology of Vision.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hamilton, R. Clinical electrophysiology of vision—commentary on current status and future prospects. Eye 35, 2341–2343 (2021). https://doi.org/10.1038/s41433-021-01592-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-021-01592-0
This article is cited by
-
Group comparisons of the individual electroretinogram time trajectories for the ascending limb of the b-wave using a raw and registered time series
BMC Research Notes (2023)
-
Visual electrophysiology and “the potential of the potentials”
Eye (2023)
-
The effect of COVID-19 on referral patterns for clinical electrophysiological testing
Documenta Ophthalmologica (2023)